On Oct 14, 2021 Abalos Therapeutics closed a Series A round and raised €31,000,000 from Boehringer Ingelheim Venture Fund, coparion, Gruenderfonds Ruhr, High-Tech Grunderfonds, Hx Bio Ventures, NRW.BANK, Seventure Partners, Ventura BioMed Investors, featuring lead investors Seventure Partners.

About the company: Abalos Therapeutics is located at Germany, Europe.

Company website: http://www.abalos-tx.com

Leave a Reply

Your email address will not be published. Required fields are marked *